HK1211960A1 - Treating vascular disease and complications thereof - Google Patents
Treating vascular disease and complications thereof Download PDFInfo
- Publication number
- HK1211960A1 HK1211960A1 HK15112832.0A HK15112832A HK1211960A1 HK 1211960 A1 HK1211960 A1 HK 1211960A1 HK 15112832 A HK15112832 A HK 15112832A HK 1211960 A1 HK1211960 A1 HK 1211960A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- complications
- vascular disease
- treating vascular
- chance
- expected
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/245—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261709754P | 2012-10-04 | 2012-10-04 | |
| US201261709754P | 2012-10-04 | ||
| PCT/US2013/062903 WO2014055544A1 (en) | 2012-10-04 | 2013-10-01 | Treating vascular disease and complications thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK42020002705.0A Addition HK40012735A (en) | 2012-10-04 | 2015-12-30 | Treating vascular disease and complications thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1211960A1 true HK1211960A1 (en) | 2016-06-03 |
Family
ID=50432830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15112832.0A HK1211960A1 (en) | 2012-10-04 | 2013-10-01 | Treating vascular disease and complications thereof |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20140099321A1 (enExample) |
| EP (3) | EP4628162A3 (enExample) |
| JP (1) | JP6460993B2 (enExample) |
| KR (2) | KR102296017B1 (enExample) |
| CN (2) | CN104684929A (enExample) |
| AU (1) | AU2013327501B2 (enExample) |
| CA (1) | CA2886747C (enExample) |
| HK (1) | HK1211960A1 (enExample) |
| IL (1) | IL237765B (enExample) |
| MX (1) | MX376241B (enExample) |
| RU (1) | RU2671955C2 (enExample) |
| WO (1) | WO2014055544A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6324720B2 (ja) | 2010-06-18 | 2018-05-16 | エックスバイオテク, インコーポレイテッドXbiotech, Inc. | 関節炎治療 |
| KR102748255B1 (ko) | 2010-08-23 | 2024-12-31 | 엑스바이오테크 인코포레이티드 | 종양성 질병들에 대한 치료 |
| US9724409B2 (en) | 2011-04-01 | 2017-08-08 | Xbiotech, Inc. | Treatment of inflammatory skin disease |
| JP6204915B2 (ja) | 2011-09-23 | 2017-09-27 | エックスバイオテク, インコーポレイテッドXbiotech, Inc. | 悪液質治療 |
| US9545441B2 (en) | 2012-09-18 | 2017-01-17 | Xbiotech, Inc. | Treatment of diabetes |
| KR20190117579A (ko) | 2017-02-16 | 2019-10-16 | 엑스바이오테크, 인크. | 화농성 한선염의 치료 |
| CN113874034A (zh) * | 2019-05-03 | 2021-12-31 | 苏黎世大学 | 脑缺血再灌注损伤的治疗 |
| KR102652849B1 (ko) | 2022-03-14 | 2024-04-01 | 한국화학연구원 | 극성 아라미드 나노섬유로 제조한 하이드로겔 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH652145A5 (de) | 1982-01-22 | 1985-10-31 | Sandoz Ag | Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen. |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| RU2235541C2 (ru) * | 1994-10-04 | 2004-09-10 | Эмори Юниверсити | Лечение атеросклероза и других сердечно-сосудистых и воспалительных заболеваний |
| JP2003500069A (ja) * | 1999-05-24 | 2003-01-07 | インタールーキン ジェネティックス インク | 再狭窄の診断及び治療薬 |
| EP1471931A4 (en) * | 2001-08-24 | 2006-06-14 | Maine Medical Ct Res Inst | NON-TRADITIONAL EXPORT OF COPPER-DEPENDENT PRO-INFLAMMATORY CYTOKINES AND METHODS, COMPOSITIONS, AND KITS THEREOF |
| WO2004100987A2 (en) * | 2003-05-06 | 2004-11-25 | Regeneron Pharmaceuticals, Inc. | Methods of using il-1 antagonists to treat neointimal hyperplasia |
| CN105467136B (zh) * | 2008-05-30 | 2018-02-16 | 埃克斯生物科技公司 | 白细胞介素‑1α抗体及使用方法 |
| CN107243077A (zh) * | 2009-05-29 | 2017-10-13 | 爱克索马美国有限责任公司 | IL‑1β抗体及其结合片段的心血管相关用途 |
| JP5812669B2 (ja) | 2011-04-27 | 2015-11-17 | キヤノン株式会社 | 画像処理装置および画像処理方法およびコンピュータプログラム。 |
-
2013
- 2013-10-01 EP EP25187641.3A patent/EP4628162A3/en active Pending
- 2013-10-01 KR KR1020157009716A patent/KR102296017B1/ko active Active
- 2013-10-01 EP EP13843772.8A patent/EP2904010A4/en not_active Ceased
- 2013-10-01 CN CN201380051667.8A patent/CN104684929A/zh active Pending
- 2013-10-01 WO PCT/US2013/062903 patent/WO2014055544A1/en not_active Ceased
- 2013-10-01 JP JP2015535742A patent/JP6460993B2/ja active Active
- 2013-10-01 EP EP18215704.0A patent/EP3524621A1/en not_active Ceased
- 2013-10-01 CA CA2886747A patent/CA2886747C/en active Active
- 2013-10-01 CN CN202110285555.5A patent/CN113018431A/zh active Pending
- 2013-10-01 HK HK15112832.0A patent/HK1211960A1/xx unknown
- 2013-10-01 AU AU2013327501A patent/AU2013327501B2/en active Active
- 2013-10-01 KR KR1020217027089A patent/KR102429919B1/ko active Active
- 2013-10-01 RU RU2015110635A patent/RU2671955C2/ru active
- 2013-10-01 MX MX2015004286A patent/MX376241B/es active IP Right Grant
- 2013-10-02 US US14/044,418 patent/US20140099321A1/en not_active Abandoned
-
2015
- 2015-03-16 IL IL237765A patent/IL237765B/en active IP Right Grant
-
2017
- 2017-11-01 US US15/800,407 patent/US20180057585A1/en not_active Abandoned
-
2021
- 2021-09-10 US US17/471,702 patent/US20210403548A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014055544A1 (en) | 2014-04-10 |
| KR20210108496A (ko) | 2021-09-02 |
| EP3524621A1 (en) | 2019-08-14 |
| AU2013327501A1 (en) | 2015-04-02 |
| IL237765B (en) | 2019-06-30 |
| MX376241B (es) | 2025-03-06 |
| RU2671955C2 (ru) | 2018-11-08 |
| KR102296017B1 (ko) | 2021-09-01 |
| IL237765A0 (en) | 2015-05-31 |
| CA2886747C (en) | 2023-12-05 |
| CN104684929A (zh) | 2015-06-03 |
| AU2013327501B2 (en) | 2018-08-09 |
| US20180057585A1 (en) | 2018-03-01 |
| US20140099321A1 (en) | 2014-04-10 |
| RU2015110635A (ru) | 2016-11-27 |
| MX2015004286A (es) | 2015-08-06 |
| JP6460993B2 (ja) | 2019-01-30 |
| JP2015531397A (ja) | 2015-11-02 |
| EP4628162A2 (en) | 2025-10-08 |
| CN113018431A (zh) | 2021-06-25 |
| KR20150063076A (ko) | 2015-06-08 |
| EP4628162A3 (en) | 2025-12-03 |
| US20210403548A1 (en) | 2021-12-30 |
| CA2886747A1 (en) | 2014-04-10 |
| EP2904010A1 (en) | 2015-08-12 |
| EP2904010A4 (en) | 2016-06-01 |
| KR102429919B1 (ko) | 2022-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1211960A1 (en) | Treating vascular disease and complications thereof | |
| WO2013079701A3 (en) | Expression of mirnas in placental tissue | |
| PH12013501790B1 (en) | Use of dpp iv inhibitors | |
| WO2013087716A3 (de) | Fgfr- binder -wirkstoff konjugate und ihre verwendung | |
| EP3501546A3 (de) | Cystein-wirkstoff konjugate und ihre verwendung | |
| WO2012138913A3 (en) | In vivo immunomagnetic hyperthermia platform for any cell or virus having a target surface receptor | |
| WO2010144678A3 (en) | Generation of vascularized human heart tissue and uses thereof | |
| JP2015531397A5 (enExample) | ||
| JOP20140344B1 (ar) | تركيبات وطرق لتقليل المضاعفات السلبية العظمي للقلب والاوعية الدموية | |
| MX2010006650A (es) | Materiales y metodos para el tratamiento de proliferacion vascular ocular patologica. | |
| WO2010102171A3 (en) | Secreted ap2 and methods of inhibiting same | |
| WO2014191738A8 (en) | Degradable haemostat composition | |
| WO2009035534A3 (en) | Treatment of ischemic eye disease by the systematic pharmaceutical activation of hypoxia inducible factor (hif) | |
| WO2013165982A3 (en) | Anti-human cytomegalvirus antibodies and use thereof | |
| HRP20161147T1 (hr) | Farmaceutski sastav i postupak njegove proizvodnje | |
| WO2012106497A3 (en) | Selection and treatment of subjects | |
| Tebeu et al. | Surgical outcome following treatment of obstetric vesicovaginal fistula among HIV-positive and HIV-negative patients in Cameroon | |
| WO2010126260A3 (ko) | 라이소포스파티드산 및 아데닐일 시클라아제 억제제를 유효성분으로 포함하는 상처 치유 촉진용 약학 조성물 | |
| WO2019055776A3 (en) | Compositions and methods for treatment of diseases involving cxcl1 function | |
| Fukunaga et al. | Chylous ascites as a rare complication after abdominal aortic aneurysm surgery | |
| RU2010127731A (ru) | Способ лечения гнойно-воспалительных осложнений у онкоурологических больных | |
| 张承磊 | The treatment strategy of special distal landing zones in endovascular repair of abdominal aortic aneurysm | |
| Liu et al. | Preventive effects of modified chitosan medical anti-adhesion membrane on postoperative intra-abdominal adhesion | |
| Mori | Clinical guidelines for tuberculosis of Japan compared with those of other countries | |
| Kanafyanova | NEURONET PREDICTION OF VISION ORGAN TRAUMA SEVERITY |